Overlap between whites and blacks in response to antihypertensive drugs

被引:81
作者
Sehgal, AR [1 ]
机构
[1] Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, Cleveland, OH 44106 USA
关键词
hypertension; drug therapy; race; meta-analysis;
D O I
10.1161/01.HYP.0000118019.28487.9c
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
On average, whites and blacks differ in their response to specific antihypertensive drugs. These differences are often highlighted in reviews and practice guidelines. However, there is wide variation in drug-associated changes in blood pressure within each race. The goal of this meta-analysis is to quantitate how often whites and blacks have similar responses to specific antihypertensive drugs. Computerized searches of MEDLINE ( 1983 to March 2003) and manual searches of references listed in identified articles were performed. Studies were included if they provided race-specific changes in blood pressure. Fifteen studies with a total of 9307 white subjects and 2902 black subjects were analyzed. For drug-associated changes in diastolic blood pressure, the mean difference between whites and blacks ranged from 0.6 to 3.0 mm Hg while the standard deviation within each race ranged from 5.0 to 10.1 mm Hg. The percentage of whites and blacks with similar drug-associated changes in diastolic blood pressure was 90% (95% confidence interval: 81 to 99) for diuretics, 90% ( 95% CI: 83 to 97) for beta-blockers, 95% ( 95% CI: 92 to 98) for calcium channel blockers, and 81% ( 95% CI: 76 to 86) for angiotensin converting enzyme inhibitors. The percentage of whites and blacks with similar drug-associated changes in systolic blood pressure ranged from 83% to 93%. In conclusion, the majority of whites and blacks have similar responses to commonly used antihypertensive drugs. Clinical decisions to use a specific drug should be based on other considerations such as efficacy in individual patients, compelling indications, and cost.
引用
收藏
页码:566 / 572
页数:7
相关论文
共 28 条
[1]   An apportionment of human DNA diversity [J].
Barbujani, G ;
Magagni, A ;
Minch, E ;
CavalliSforza, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4516-4519
[2]   A COMPARISON OF THE SAFETY OF THERAPEUTICALLY EQUIVALENT DOSES OF ISRADIPINE AND DILTIAZEM FOR TREATMENT OF ESSENTIAL-HYPERTENSION [J].
BLACK, HR ;
LEWIN, AJ ;
STEIN, GH ;
MACCARTHY, EP ;
HAMILTON, JH ;
HAMILTON, BP ;
MADIAS, NE ;
KOCHAR, MS ;
ABRAMS, AP ;
ISAACSOHN, JL ;
GIBBONS, ME ;
MATTHEWS, KP .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (03) :141-146
[3]   The importance of race and ethnic background in biomedical research and clinical practice [J].
Burchard, EG ;
Ziv, E ;
Coyle, N ;
Gomez, SL ;
Tang, H ;
Karter, AJ ;
Mountain, JL ;
Pérez-Stable, EJ ;
Sheppard, D ;
Risch, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1170-1175
[4]  
CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V2869, P2560
[5]   Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension [J].
Chrysant, SG ;
Fagan, T ;
Glazer, R ;
Kriegman, A .
ARCHIVES OF FAMILY MEDICINE, 1996, 5 (01) :17-24
[6]   Race and genomics [J].
Cooper, RS ;
Kaufman, JS ;
Ward, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1166-1170
[7]  
Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393
[8]   Management of high blood pressure in African Americans - Consensus statement of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks [J].
Douglas, JG ;
Bakris, GL ;
Epstein, M ;
Ferdinand, KC ;
Ferrario, C ;
Flack, JM ;
Jamerson, KA ;
Jones, WE ;
Haywood, J ;
Maxey, R ;
Ofili, EO ;
Sanders, E ;
Schiffrin, EL ;
Sica, DA ;
Sowers, JR ;
Vidt, DG .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :525-541
[9]  
FLAMENBAUM W, 1985, J NATL MED ASSOC, V77, P14
[10]  
GAVRAS H, 1986, CLIN THER, V9, P24